It has been argued for decades that meaningful incentives are needed for substantially more individuals to donate organs. Existing and hypothetical approaches to improve organ supply are outlined below.
Planning and financing healthcare is a challenging task for individuals, private insurance providers and governments. Public and private insurances must cater for a vast number of people ideally equally across all income classes. Indeed, increased healthcare spending can reduce inequalities in mortality between socioeconomic groups (Mackenbach, Hu et al. 2017). However, there can be an inherent conflict between the utility […]
I finally took the time for a wee excursion down the river Don to have a look at the new hydro energy station. It all started as a community project and successfully went through a few funding rounds, including selling bonds to private investors. Find out more on their website.
After I tweeted about my recent post about Immunium, another Twitter user made me aware of iCancer. Why? – Because the clinical trial financed through the iCancer fundraising campaign used the Ad5PTDf35-adenovirus vector which Immunicum includes as one of their treatment platforms under development.
I thought I kick off the year with an article about Immunicum, a Swedish company I stumbled across a week or so ago. As an immunologist by training I have a soft spot for companies looking to exploit the versatility and strength of our own immune system. Immunicum does just that. In their own words, they aim to create “the […]
Exsel Group are certainly doing something right if the company’s recent accolades are anything to go by. Having started in 2014 with just three members of staff; today the IT and communications company can boast a turnover of almost £3million, 48 members of staff and three offices across Scotland. With this in mind, it’s little surprise that the business has just […]